Published in

Taylor and Francis Group, Journal of Endocrinology, Metabolism and Diabetes of South Africa, 3(16), p. 122-127, 2011

DOI: 10.1080/22201009.2011.10872263

Links

Tools

Export citation

Search in Google Scholar

Should haemoglobin A<sub>1c</sub>be used for the diagnosis of diabetes mellitus in South Africa?

Journal article published in 2011 by Ja George ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Diabetes is an important medical problem in sub-Saharan Africa. It has traditionally been diagnosed by means of fasting plasma glucose, random blood glucose or an oral glucose tolerance test. Each of these has limitations and, in 2009, an expert committee of the American Diabetes Association recommended using the haemoglobin A1c (HbA1c) to diagnose diabetes mellitus.1 The aim of this paper is to analyse the advantages and disadvantages of using HbA1c as a diagnostic method for diabetes, and its applicability in the South African setting.Keywords: diabetes, glycated haemoglobin, fasting plasma glucose, oral glucose tolerance test